Virus-Like Particles Expressing the Nucleocapsid Gene as an Efficient Vaccine Against Rift Valley Fever Virus

Virus‑like particles as a vaccine delivery system: Myths and facts

(2011) Polly Roy et al.   Human vaccines & immunotherapeutics

Reverse genetics technology for Rift Valley fever virus: Current and future applications for the development of therapeutics and vaccines

(2009) Michele Bouloy et al.   ANTIVIRAL RESEARCH

An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus

(2009) M. T. HEISE et al.   EPIDEMIOLOGY AND INFECTION

Rift Valley fever virus

(2009) Brian H. Bird et al.   JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION

Rift Valley fever vaccines

(2009) Tetsuro Ikegami et al.   VACCINE

Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus

(2009) Jonas Näslund et al.   VIROLOGY

Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses

(2009) Matthias Habjan et al.   VIROLOGY

Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs

(2009) Nina Lagerqvist et al.   Virology Journal

Bunyaviruses and the Type I Interferon System

(2009) Richard Elliott et al.   Viruses-Basel

T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus

(2008) M. Habjan et al.   JOURNAL OF GENERAL VIROLOGY

Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated Animals

(2008) B. H. Bird et al.   JOURNAL OF VIROLOGY

Immunization with Toscana virus N-Gc proteins protects mice against virus challenge

(2008) Gianni Gori Savellini et al.   VIROLOGY